Webinar Schedule
December 11th, 2024
Abstract
Cell therapy, a rapidly evolving branch of regenerative medicine, holds the potential to revolutionize the way we treat a variety of diseases, particularly in the field of oncology. Among the most promising developments within this field is Chimeric Antigen Receptor T-cell (CAR-T) therapy, which leverages the body's own immune system to target and destroy cancer cells. This innovative treatment involves the genetic modification of a patient's own T-cells to enhance their ability to target and eliminate cancer cells.
In CAR-T therapy, T-cells are extracted from the patient's blood and then engineered in a laboratory to express chimeric antigen receptors (CARs). These CARs are designed to bind to specific antigens present on the surface of cancer cells. Once the T-cells have been modified and multiplied, they are reintroduced into the patient’s body via infusion. Upon reinfusion, these modified T-cells, now armed with CARs, can seek out and eliminate cancer cells with heightened specificity and efficiency. This personalized immunotherapy not only enhances the body's natural defenses against cancer but also offers renewed hope for patients who have exhausted conventional treatment options.
In this webinar, we will discuss the research progress in cell therapy, with a focus on ongoing studies that explore both the benefits and limitations of expanding CAR-T therapy. This promising development marks a pivotal shift toward more targeted and effective treatments, positioning CAR-T cell therapy as a powerful ally in the fight against cancer and other diseases.
Key Content
1. Introduction to Cell Therapy and CAR-T
2. Mechanism and Benefits of CAR-T Therapy
3. Current Research and Future Prospects
Speaker
Ying Zhou PhD
Product Manager, CUSABIO
Dr. Ying Zhou is a Product Manager at CUSABIO, responsible for product marketing, development, and optimization. Before joining CUSABIO, Dr. Zhou earned her Ph.D. in Biology and Biotechnology from Worcester Polytechnic Institute in the United States. Following her graduation, she pursued post-doctoral training at the University of California, Davis. Dr. Zhou's expertise lies in molecular biology and protein science, specifically in mRNA expression and regulation. She is particularly interested in mRNA stability and RNA-interacting proteins.
